Azenta acquires gene library maker SynPlexity, licenses DNA synthesis tech from Elegen

Azenta announced the acquisition of gene library maker SynPlexity and an exclusive license with Elegen for DNA synthesis technology. Terms were not disclosed.

Detected & updated continuously · Source: Nebula

Story subjects

Azenta, Inc.SynPlexityElegen

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula